Objective To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS). Methods Data collection from neurologists attending to patients with MS at specialized units in Brazil. Results Data from 103 patient...
Similar Items
-
by: Yára Dadalti Fragoso, et al.
Published: (2013-03-01) -
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive
by: Yara Dadalti Fragoso, et al.
Published: (2013-10-01) -
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2016-08-01) -
Evolução favorável de recidiva de infecção por varicela zoster (cobreiro) durante uso de natalizumabe em paciente com esclerose múltipla: relato de caso
by: Diego Rafhael Soares Carvalho Feitosa, et al.
Published: (2017-04-01) -
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers
by: Enedina Maria Lobato de Oliveira, et al.
Published: (2015-09-01)